Hangzhou Tigermed Consulting Co Ltd
SZSE:300347

Watchlist Manager
Hangzhou Tigermed Consulting Co Ltd Logo
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Watchlist
Price: 67.6 CNY -0.5%
Market Cap: 50.1B CNY
Have any thoughts about
Hangzhou Tigermed Consulting Co Ltd?
Write Note

Net Margin
Hangzhou Tigermed Consulting Co Ltd

16.1%
Current
36%
Average
-0.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
16.1%
=
Net Income
1.1B
/
Revenue
7B

Net Margin Across Competitors

Country CN
Market Cap 50.1B CNY
Net Margin
16%
Country US
Market Cap 1.3T USD
Net Margin
9%
Country US
Market Cap 207.3B USD
Net Margin
14%
Country US
Market Cap 174.3B USD
Net Margin
18%
Country KR
Market Cap 67.6T KRW
Net Margin
24%
Country CH
Market Cap 40.2B CHF
Net Margin
9%
Country US
Market Cap 38B USD
Net Margin
9%
Country US
Market Cap 38.6B USD
Net Margin
22%
Country US
Market Cap 26.7B USD
Net Margin
21%
Country US
Market Cap 25.1B USD
Net Margin
17%
Country US
Market Cap 23.4B USD
Net Margin
-36%

Profitability Report

View the profitability report to see the full profitability analysis for Hangzhou Tigermed Consulting Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
16.1%
=
Net Income
1.1B
/
Revenue
7B
What is the Net Margin of Hangzhou Tigermed Consulting Co Ltd?

Based on Hangzhou Tigermed Consulting Co Ltd's most recent financial statements, the company has Net Margin of 16.1%.